Company Updates
The company using innovation to fight cancer
Varian is a global leader in the field of radiation therapy with around 50% market share.
Clearmatch offers a low-risk alternative to Term Deposits returning 4.2%* with Premium Funding Trust
This week the RBA slashed interest rates to a record low of 1.25%, delivering what many economists expect to be the first of two rate cuts in coming months.
Positive results for Walker Capital May returns
Swing Trading, Multi-Strategy and the High Growth Strategy all posted positive returns at 3.39%, 1.1% and 3.85% respectively.
Geocon reaffirmed position as Canberra’s premier property developer and most identifiable brand in 2019
Geocon reaffirmed its position as Canberra’s premier property developer and most identifiable brand in 2019, releasing and building more than 2000 new apartments to the market, across 10 projects.
Global concerns impacting the Australian market and a mixed month for TAIM Funds
Global growth fears began to take hold during May, fuelled by escalating trade tensions between China and the US.
Elixinol Global raises A$50m to accelerate US expansion
Elixinol s pleased to announce that it has successfully completed an institutional placement to fund its ongoing expansion initiatives, with a particular focus on growing its USA CBD business
CRIISP features in popular Australian fintech media following launch
Following the highly successful launch of our new end-to-end, SaaS platform, CRIISP, the technology has sparked the interest of fintech media publications nationally.
Recce Pharma seeks range of options to advance new antibiotic, including partnerships, M&A
Recce Pharmaceuticals [ASX: RCE], a Sydney, Australia-based synthetic polymer antibiotic developer, is actively seeking partnership or M&A opportunities to advance its Phase 1-ready lead compound.
MMA training program secures $2M funding from big name backers & seeks new expansion round
Wimp 2 Warrior – an intensive 20-week mixed martial arts (MMA) training program has caught the eye of a top group of Australian investors in the tune of $2 million.
Backed By Leading Investment Groups and Family Offices
